Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403.

Xiaoxi LingJoseph D LatocheCindy J ChoyBrenda F KurlandCharles M LaymonYijen WuNathan SalamachaDing ShenJonathan J GerunthoLora H RigattiHillarie P WindishBeatrice Langton-WebsterClifford E BerkmanCarolyn J Anderson

Published in: Molecular imaging and biology (2021)

The preclinical efficacy and dosimetry of CTT1403 suggest that this agent has significant potential to be safe and effective in humans.

Keyphrases

pet imaging
cancer therapy
cell therapy
pet ct
high resolution
monte carlo
stem cells
binding protein
mass spectrometry
risk assessment
photodynamic therapy
climate change
positron emission tomography